You may be able to start once your body has recovered and if youre not breastfeeding
Combining tirzepatide and semaglutide increases nausea, vomiting, and GI side effects without evidence of added benefit because both medications activate the same GLP-1 receptor pathway
The ongoing CONFIDENCE trial (NCT05254002) is an international randomised controlled double-blind trial that will directly assess the effects of finerenone plus empagliflozin on albuminuria and characterise the efficacy and safety of this drug combination in the setting of type 2 diabetes
i wonder if this multi dose vial was formulated by your labs..that is ok but i prefer the single dose vials
Make sure you discuss the complications with your doctor
Declining IGF-1 despite consistent dosing indicates receptor downregulation Tesamorelin + MK-677 protocol: MK-677 12.525mg oral, taken in the evening with or without food Tesamorelin 12mg subcutaneous 6090 minutes later, before bed No cycling required for MK-677 monotherapy, though some researchers implement 5 days on / 2 days off to preserve insulin sensitivity Dose titration for new users: Start tesamorelin at 1mg daily for the first week to assess tolerance (injection site reactions, transient hyperglycemia, or joint discomfort are the most common initial responses)
